 |
|
 |
Frank: Diabetes, high blood pressure, BMI 29*
Frank is 44 years old, 5 feet 8 inches tall, and weighs 190 lbs. This means
his BMI is 29. A BMI of 27 or higher is considered overweight.
Frank is taking a prescription medicine to help manage his type 2 diabetes.
He also has hypertension (high blood pressure). Both hypertension and
diabetes are conditions that can improve with weight loss.
First and foremost, Frank wants to get his diabetes under control. His
doctor told him about the importance of changing his dietary habits and
activity level. The doctor described the link between being overweight and
having type 2 diabetes, and told Frank that he may be able to manage his
diabetes with less medicine if he lost weight. Diabetes increases Frank's
risk of other medical conditions, including heart disease, nerve damage,
vision problems and kidney disease. By shedding extra pounds, Frank may be
able to reduce his risks for these complications.
Frank has a number of health-related goals - goals that a combination of
XENICAL and a reduced-calorie diet can help him achieve.
Results with XENICAL
Weight loss with XENICAL plus diet has been shown to reduce the risk or
delay the progression of impaired glucose tolerance and improve high blood
pressure.
In a study of patients who were being treated with oral medication for
their type 2 diabetes, those treated with XENICAL plus diet lost 14 lbs of
body weight, while those on diet alone lost only 9 lbs after 1 year. In
addition, the patients' doctors were able to reduce or discontinue the dose
of their diabetes medication in almost 43% of patients on XENICAL plus diet
compared to 29% of patients on diet alone.
Note: Do not change or discontinue your use of any prescribed medication
without checking with your doctor.
The long-term benefits of orlistat on
weight-related illnesses and life expectancy have not been studied.
*These patients are not real individuals. They are representative patient
profiles based on data from clinical studies.
Return to Look Who's Taking XENICAL
|
|
|